Farmabios

Axplora Announces €35 Million Expansion at Farmabios

Axplora to expand its Farmabios site in Gropello Cairoli, Italy, with a €35 million investment.

Axplora’s Farmabios Gets cGMP Approval for New Production Unit in Italy

Farmabios, a company of the Axplora group founded in 2022, has received the cGMP approval from AIFA (national public body regulating medicines for human use in Italy) for the first line of its new production unit at Gropello Cairoli, Italy, expanding its large scale manufacturing capabilities for high potent active pharmaceutical ingredients (HPAPIs) and steroids.

Topics • Innovation

Axplora Aims to Make Pharmaceutical Supply Chains More Stable

Interview with Sylke Hassel, previous CEO of PharmaZell and current CEO of Axplora following the merger with Novasep.

Top-Feature

Sasol

From Data to Decisions: Digital Tools Reshaping the Chemical and Life Sciences Landscape

Brenntag SE

Brenntag Downsizes Management Board, Retains Both Divisions

BIO Deutschland e.V.

German Biotech Days 2026: Biotechnology as The Key to Industrial Competitiveness

Dow Chemical Company

Anchored in Sustainability

CHEManager International c/o Wiley-VCH GmbH

API Manufacturing

Special Issue

Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Axplora

Farmabios

Axplora Announces €35 Million Expansion at Farmabios

Axplora’s Farmabios Gets cGMP Approval for New Production Unit in Italy

Axplora Aims to Make Pharmaceutical Supply Chains More Stable

Top-Feature

Leading Transformation

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

Advanced Recycling Conference 2025: New Paths to the Circular Economy

Leading the way. Driving results.

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development